Aster DM Healthcare shines post announcing clinical excellence hub in Cayman Islands

Aster DM Healthcare and Cayman Islands Government today announced an agreement for making the Cayman Islands as Aster’s clinical excellence hub for the Western hemisphere, serving North America, the Caribbean region, Canada, Latin & South America. 

As per the terms of the agreement, Aster initially would develop around 150-bed comprehensive, tertiary and quaternary care hospital, with an opportunity to expand in the future, depending upon the need along with an assisted living facility and healthcare university in the long-term. 

Reacting to this, the stock of Aster DM Healthcare today jumped more than 4 per cent and made an intraday high of Rs 166.90 per share. 

The company reported a net profit of Rs 41.22 crore in Q2FY21, an increase of 524.55 per cent. It had reported a profit of Rs 6.60 crore in Q2FY20. The company reported net sales of Rs 2,267.71 crore for Q2FY21, an increase of 8.67 per cent as against the net sales of Rs 2,086.88 crore for Q2FY20. 

Aster DM Healthcare Limited is a healthcare service provider. The company operates in various segments of the healthcare industry, which include hospitals, clinics, retail pharmacies, and also, provides healthcare services. 

According to BSE data, the stock traded at a price-to-book ratio of 2.77. The share price of the company closed at Rs 165.60, up by 3.37 per cent on BSE.